These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17661690)

  • 1. Folate metabolism as a source of molecular targets for antimalarials.
    Yuthavong Y; Kamchonwongpaisan S; Leartsakulpanich U; Chitnumsub P
    Future Microbiol; 2006 Jun; 1(1):113-25. PubMed ID: 17661690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance of malaria parasites to antifolates.
    Gregson A; Plowe CV
    Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the vitamin biosynthesis pathways for the treatment of malaria.
    Kronenberger T; Schettert I; Wrenger C
    Future Med Chem; 2013 May; 5(7):769-79. PubMed ID: 23651091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
    Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
    Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
    Nzila A
    Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate metabolism in malaria.
    Ferone R
    Bull World Health Organ; 1977; 55(2-3):291-8. PubMed ID: 338184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protozoa (plasmodium) : mechanisms of resistance to antimalarials].
    Iwagami M; Kano S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():497-501. PubMed ID: 17455670
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
    Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L
    Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical aspects of drug action and resistance in malaria parasites.
    Yuthavong Y; Panijpan B; Ruenwongsa P; Sirawaraporn W
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):459-72. PubMed ID: 3913002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence and drug resistance in malaria parasites.
    Stein WD; Sanchez CP; Lanzer M
    Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistant malaria].
    Kano S
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():214-20. PubMed ID: 12717974
    [No Abstract]   [Full Text] [Related]  

  • 12. Folate metabolism in human malaria parasites--75 years on.
    Müller IB; Hyde JE
    Mol Biochem Parasitol; 2013 Mar; 188(1):63-77. PubMed ID: 23500968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium.
    Nzila A; Ward SA; Marsh K; Sims PF; Hyde JE
    Trends Parasitol; 2005 Jul; 21(7):334-9. PubMed ID: 15936248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S
    J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and drug resistance in malaria.
    Cowman AF; Foote SJ
    Int J Parasitol; 1990 Jul; 20(4):503-13. PubMed ID: 2210944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum.
    Mita T
    Acta Trop; 2010 Jun; 114(3):166-70. PubMed ID: 19607799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid metabolism and its disruption by pharmacologic agents.
    Huennekens FM; Duffy TH; Vitols KS
    NCI Monogr; 1987; (5):1-8. PubMed ID: 3124003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.